Reply to Letter Regarding “Is It Safe to Give Meloxicam or Celecoxib to Chronically Anticoagulated Patients Following Primary Total Knee Arthroplasty?”
The Journal of Arthroplasty · 2026-07 · 41 (7) · e76-e77
DOI: 10.1016/j.arth.2026.01.076 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Journal of Arthroplasty, 2026-07. Verfasst von Jiabin Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Critical Care, Hospital for Special Surgery, New York, New York. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Anesthesiology and Critical Care, Hospital for Special Surgery, New York, New York.
- Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, New York.
Zitieren
APA
Liu, J., & Lee, G. C. (2026). Reply to Letter Regarding “Is It Safe to Give Meloxicam or Celecoxib to Chronically Anticoagulated Patients Following Primary Total Knee Arthroplasty?”. The Journal of Arthroplasty, 41(7), e76-e77. https://doi.org/10.1016/j.arth.2026.01.076
Vancouver
Liu J, Lee GC. Reply to Letter Regarding “Is It Safe to Give Meloxicam or Celecoxib to Chronically Anticoagulated Patients Following Primary Total Knee Arthroplasty?”. The Journal of Arthroplasty. 2026;41(7):e76-e77. doi:10.1016/j.arth.2026.01.076
BibTeX
@article{Liu2026,
author = {Liu, Jiabin and Lee, Gwo-Chin},
title = {Reply to Letter Regarding “Is It Safe to Give Meloxicam or Celecoxib to Chronically Anticoagulated Patients Following Primary Total Knee Arthroplasty?”},
journal = {The Journal of Arthroplasty},
year = {2026},
volume = {41},
number = {7},
pages = {e76--e77},
doi = {10.1016/j.arth.2026.01.076}
}
EUVIMED